News Focus
News Focus
icon url

Northstar42

10/13/17 6:32 AM

#17622 RE: trding #17621

FDA "...can conduct an interim efficacy analysis of primary endpoint." Very good news and the key to the future IMO.
 
icon url

buckysherm

10/13/17 7:03 AM

#17628 RE: trding #17621

Who can say the FDA won't change the enrollment requirements again ? They CAN start an efficacy analysis.... will they ? I can imagine a govt worker putting this off for awhile.